![]() |
市場調査レポート
商品コード
1576926
創傷閉鎖デバイスの世界市場:洞察、競合情勢、市場予測:2030年Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
創傷閉鎖デバイスの世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 2024年10月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の創傷閉鎖デバイスの市場規模は、2023年に148億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に7.40%のCAGRで拡大し、2030年には226億4,000万米ドルに達すると予測されています。創傷閉鎖デバイスの需要は、主に慢性創傷と急性創傷の罹患率の上昇が後押ししています。さらに、外科手術の増加、主要市場参入企業による製品の上市と承認の増加が、2024年から2030年までの予測期間中に創傷閉鎖デバイス市場全体を大きく押し上げる要因となっています。
Diabetes Feet Australia(DFA)が提供した最新データ(2022年)によると、オーストラリアでは、人口10万人あたり30万人が糖尿病性足部疾患(DFD)を発症するリスクがあり、そのうち5万人がすでに糖尿病性足部疾患を患っています。このうち、12,500人が糖尿病に関連した切断手術を受け、1,000人が現在DFDのために入院しています。さらに、IDFアトラス・レポート(2022年)が提供した最近のデータと統計によると、アフリカ諸国では、糖尿病性足潰瘍(DFU)の割合は10.0%から30.0%であり、下肢切断(LLA)の有病率は3.0%から35.0%です。糖尿病性足潰瘍は慢性創傷であり、専門的な治療や高度な創傷閉鎖ソリューションが必要となることが多いです。このような潰瘍の有病率が上昇するにつれ、これらの創傷を効果的に管理・閉鎖できる製品に対する需要が高まっています。さらに、糖尿病関連の切断では、創傷初期と継続的ケアの両方に創傷閉鎖デバイスが必要になることが多いです。高度な創傷閉鎖製品は、手術部位の管理と治癒を促進し、さらなる合併症や再手術の可能性を減らすのに役立ちます。このため、創傷閉鎖デバイスの市場需要は予測期間中に拡大する見込みです。
さらに、企業は創傷閉鎖デバイスの生産を拡大し、規制当局の承認を確保することで、市場でのプレゼンスを戦略的に拡大し、さらなる成長を促しています。例えば、2023年6月、Sree Chitra Tirunal Institute for Medical Sciences and Technology(SCTIMST)は、Choledermと呼ばれる高度な創傷ケア製品について中央医薬品標準管理機構(CDSCO)から承認を受けました。Choledermは火傷や糖尿病性創傷を含む様々な皮膚創傷の治癒を早めるために使用されます。Choledermは治療費を削減し、高度創傷治療をより手頃なものにすると期待されています。
しかし、低侵襲手術への嗜好の高まりや感染リスクは、創傷閉鎖デバイスの今後の市場を阻害する可能性があります。
当レポートでは、世界の創傷閉鎖デバイス市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Wound Closure Devices by Product Type (Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic and acute wounds, increase in surgical procedure across the globe, and increase in product launches and approvals by the key market players.
The global wound closure devices market was valued at USD 14.82 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 22.64 billion by 2030. The demand for wound closure devices is primarily being boosted by the rising incidence of chronic and acute wounds. Additionally, increasing surgical procedures, and growing product launches and approvals by the key market players are some of the factors responsible for significantly boosting the overall market for wound closure devices during the forecast period from 2024 to 2030.
Wound Closure Devices Market Dynamics:
According to the latest data provided by the Diabetes Feet Australia (DFA) (2022), in Australia, 300,000 individuals are at risk of developing diabetic foot disease (DFD) per 100,000 population, with 50,000 already living with the condition. Of these, 12,500 people have undergone diabetes-related amputations, and 1,000 are currently hospitalized due to DFD. Additionally, as per the recent data and stats provided by IDF Atlas Report (2022), in African countries, the rates of diabetic foot ulcers (DFU) range from 10.0% to 30.0%, while the prevalence of lower limb amputations (LLA) varies between 3.0% and 35.0%. Diabetic foot ulcers are chronic wounds that often require specialized treatment and advanced wound closure solutions. As the prevalence of these ulcers rises, there is a growing demand for products that can effectively manage and close these wounds. Additionally, diabetic-related amputations often require wound closure devices for both the initial wound and ongoing care. Advanced wound closure products help manage surgical sites and promote healing, reducing the likelihood of further complications and repeat surgeries. Thus, the market demand for wound closure device is expected to escalate during the forecasted period.
According to the recent data provided by the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Additionally, Finland recorded 15,870 surgical procedures per 100,000 population in the same year. As the number of surgical procedures rises, whether due to a growing population, advancements in medical technology, or more surgeries being performed for various conditions, the need for wound closure devices correspondingly increases thereby escalating the overall market.
Additionally, companies are amplifying their production of wound closure devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in June 2023, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) received approval from the Central Drugs Standard Control Organization (CDSCO) for its advanced wound care product called Cholederm. It is used for faster healing of various skin wounds, including burns and diabetic wounds. Cholederm is expected to reduce treatment costs and make advanced wound care more affordable.
Thus, the factors mentioned above are likely to boost the market of wound closure devices during the forecasted period.
However, the rising preference of minimally invasive surgeries and risk of infection may hinder the future market of wound closure devices.
Wound Closure Devices Market Segment Analysis:
Wound Closure Devices by Product Type (Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of wound closure devices market the sutures are expected to hold a significant share in 2023. Sutures play a significant role in boosting the overall market for wound closure devices due to their widespread use, versatility, and continuous innovation. Sutures are used in a variety of surgical procedures, from minor outpatient surgeries to major operations. Their versatility across different types of wounds and surgeries contributes to their high demand. Sutures are applicable in general surgery, orthopedic surgery, gynecological procedures, and more, broadening their market appeal. Additionally, the development of advanced materials, such as bioabsorbable sutures, antimicrobial-coated sutures, and high-strength synthetic fibers, has enhanced the performance and safety of sutures, driving their adoption. Furthermore, sutures are generally cost-effective compared to some other wound closure options. Their affordability makes them a preferred choice, especially in low-resource settings or where budget constraints are a concern. Moreover, sutures that are compatible with new and minimally invasive surgical techniques, such as laparoscopic surgery, drive their usage in modern medical practices. Sutures used in conjunction with other advanced surgical devices and technologies, such as robotic-assisted surgery, enhance their market presence.
Furthermore, growing recommendation by the government organizations for use of technologically advanced sutures is also a factor that will boost the market growth of sutures. For instance, recently in June 2021, Ethicon Plus sutures became the first-ever suture with antibacterial protection to be recommended for use in NHS by NICE Medical Technologies Guidance as it has been shown to reduce the risk of surgical site infections (SSIs) by nearly 30%.
Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global wound closure devices market during the forecast period.
North America is expected to dominate the overall wound closure devices market:
North America is expected to account for the highest proportion of the wound closure devices market in 2023, out of all regions. This can be ascribed to the increasing incidence of chronic and acute wound across the region, growing surgical procedures, and the presence of key market players engaged in merger, acquisition, product launch, and other market activities across the region, which will further escalate the market of wound closure devices during the forecast period.
As per the American Society for Biochemistry and Molecular Biology in the year 2021, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. The above mentioned source further stated that about 2.8 million people suffer from Traumatic Brain Injury (TBI) each year in the United States from which 2,80,000 people result in hospitalizations.
Additionally, as per the recent data provided by the World Bank Group, in 2021, approximately 6,928 surgical procedures were performed per 100,000 population in Canada.
As per the recent data provided by Centre for Disease Control and Prevention (2024), in 2021, 38.4 million people of all ages or 11.6% of the U.S. population had diabetes. Additionally, as per the same source, 80% of Lower-limb amputations (LLAs) are a result of complications from diabetes.
As the global prevalence of diabetes increases, the number of individuals experiencing diabetic wounds and requiring surgical interventions also rises. This leads to higher demand for wound closure devices tailored to managing diabetes-related complications. Furthermore, the rise in surgical procedures, including elective and emergency surgeries, increases the need for wound closure devices. This includes both minor procedures and major surgeries where effective wound closure is crucial thereby escalating the overall market of wound closure devices.
Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the wound closure devices market. For instance, in October 2023, DuPont announced the introduction of its new DuPont(TM) Liveo(TM) MG 7-9960 Soft Skin Adhesive. The higher-adhesion, low-cyclics silicone soft skin adhesive (SSA) was designed for advanced wound care dressings and for adhering medical devices to the skin for long wear time and gentle removal.
Therefore, the above-mentioned factors are expected to bolster the growth of the wound closure devices market in the North America during the forecast period.
Wound Closure Devices Market Key Players:
Some of the key market players operating in the wound closure devices market include Medtronic, 3M, Johnson & Johnson, B. Braun Melsungen AG, Baxter, Smith & Nephew, Stryker, Chemence Medical, Inc., Healthium Medtech, Meril Life Sciences Pvt. Ltd., Futura Surgicare Pvt Ltd. Advanced Medical Solutions Group plc, Microcure (Suzhou) Medical Technology Co., Ltd., CooperSurgical Inc, Adhezion Biomedical, CENTENIAL SURGICAL SUTURE LTD, Cardinal Health, Dukal LLC, ORION SUTURES INDIA PVT LTD, Lotus Surgicals, and others.
Recent Developmental Activities in the Wound Closure Devices Market:
Key Takeaways From the Wound Closure Devices Market Report Study:
Target Audience who can be Benefited From This Wound Closure Devices Market Report Study:
Frequently Asked Questions for the Wound Closure Devices Market: